Decreased pro-inflammatory immune responses during recurrent acute HCV infections in HIV co-infected patients

References

1. Hullegie SJ, Arends JE, Rijnders BJA, Irving WL, Salmon D et al. Current knowledge and future perspectives on acute hepatitis C infection. Clin Microbiol Infect 2015; 21:797.e9–797.e17 [View Article]
   [Google Scholar]
2. Maan R, van der Meer AJ. Recent advances in managing chronic HCV infection: focus on therapy in patients with severe liver disease. F1000Res 2016; 5:367 [View Article][PubMed]
   [Google Scholar]
3. Martin NK, Thornton A, Hickman M, Sabin C, Nelson M et al. Can Hepatitis C virus (HCV) direct-acting antiviral treatment as prevention reverse the HCV epidemic among men who have sex with men in the United Kingdom? Epidemiological and modeling insights. Clin Infect Dis 2016; 62:1072–1080 [View Article][PubMed]
   [Google Scholar]
4. Heydtmann M, Adams DH. Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology 2009; 49:676–688 [View Article][PubMed]
   [Google Scholar]
5. Claassen MA, Janssen HL, Boonstra A. Role of T cell immunity in hepatitis C virus infections. Curr Opin Virol 2013; 3:461–467 [View Article][PubMed]
   [Google Scholar]
6. Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L, Kasprowicz V, Nolan BE et al. Broadly directed virus-specific CD4⁺ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J Exp Med 2012; 209:61–75 [View Article][PubMed]
   [Google Scholar]
7. Dustin LB, Rice CM. Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol 2007; 25:71–99 [View Article][PubMed]
   [Google Scholar]
8. Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL et al. Hepatitis C virus reinfection and spontaneous clearance of reinfection–the InC3 study. J Infect Dis 2015; 212:1407–1419 [View Article][PubMed]
   [Google Scholar]
9. Thomas XV, Grady BP, Van Der Meer JT, Ho CK, Vanhommerig JW et al. Genetic characterization of multiple hepatitis C virus infections following acute infection in HIV-infected men who have sex with men. AIDS 2015; 29:2287–2295 [View Article][PubMed]
   [Google Scholar]
10. Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L et al. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 2010; 138:315–324 [View Article][PubMed]
    [Google Scholar]
11. Hajarizadeh B, Lamoury FM, Feld JJ, Amin J, Keoshkerian E et al. Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection. Virol J 2016; 13:32 [View Article][PubMed]
    [Google Scholar]
12. Chattergoon MA, Levine JS, Latanich R, Osburn WO, Thomas DL et al. High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection. J Infect Dis 2011; 204:1730–1740 [View Article][PubMed]
    [Google Scholar]
13. Spaan M, Claassen MA, Hou J, Janssen HL, de Knegt RJ et al. The intrahepatic T cell compartment does not normalize years after therapy-induced hepatitis C virus eradication. J Infect Dis 2015; 212:386–390 [View Article][PubMed]
    [Google Scholar]
14. Park SH, Veerapu NS, Shin EC, Biancotto A, Mccoy JP et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med 2013; 19:1638–1642 [View Article][PubMed]
    [Google Scholar]
15. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 2007; 7:875–888 [View Article][PubMed]
    [Google Scholar]
16. Sighem A, Gras L, Smit C, Stolte I, Reiss P et al. Monitoring Report 2014: Monitoring of Human Immunodeficiency Virus Infection in the Netherlands Amsterdam: 2014
    [Google Scholar]